Funding for this research was provided by:
PATH's Malaria Vaccine Initiative
Received: 6 September 2022
Accepted: 15 February 2023
First Online: 7 April 2023
: The study protocol (file number NL63594.091.17) and its amendments were approved by the Netherlands’ Central Committee on Research Involving Human Subjects , and the Western Institutional Review Board. All study participants consented to trial inclusion.
: Not applicable.
: The authors declare they have no competing interests.